Specifically, immunoglobulin G (IgG) oligoclonal bands have been a long-standing biomarker of MS, though immunoglobulin M (IgM) oligoclonal bands have also demonstrated elevation in MS patients and predict a more aggressive disease course [2]. This evidence concerns the gene CD40LG and myeloid sarcoma.